Create an Epic dot phrase for an 80‑year‑old patient with an acute hip fracture and chronic systolic heart failure on a dobutamine infusion who is hemodynamically stable.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epic Dot Phrase: 80-Year-Old with Hip Fracture and Heart Failure on Dobutamine

Patient Presentation

  • 80-year-old with acute hip fracture
  • Chronic systolic heart failure, currently on dobutamine infusion
  • Hemodynamically stable

Pre-Operative Cardiac Assessment

Current Inotropic Support

  • Dobutamine infusion is running at _____ µg/kg/min (typical range 2–20 µg/kg/min) 1
  • Indication for dobutamine: low cardiac output state with systolic BP 85–110 mmHg and signs of hypoperfusion 1
  • Current hemodynamics: HR _____, BP _____, cardiac index _____ L/min/m² (target >2.0) 1
  • Continuous ECG monitoring in place for arrhythmia detection 2
  • Arterial line present: Yes/No (mandatory for accurate BP monitoring during cement insertion) 1

Heart Failure Severity

  • NYHA functional class: _____
  • Left ventricular ejection fraction: _____% (if known)
  • Recent echocardiogram findings: _____
  • Signs of congestion: pulmonary edema (Yes/No), elevated JVP (Yes/No), peripheral edema (Yes/No) 1
  • End-organ perfusion markers: lactate _____ mmol/L (target <2), urine output _____ mL/kg/h (target >0.5), mental status _____ 1

Surgical Timing Decision

Surgery should proceed within 36–48 hours of admission despite dobutamine requirement 1

  • Delaying surgery beyond 48 hours increases mortality, pressure sores, pneumonia, and thromboembolic complications 1
  • There is no evidence that delaying surgery for "cardiac optimization" improves outcomes 1
  • The only absolute contraindications to proceeding are: active myocardial infarction, uncontrolled arrhythmia requiring immediate treatment, or severe aortic stenosis requiring urgent echocardiography 1

Intra-Operative Anesthetic Plan

Monitoring Requirements

  • Invasive arterial line is mandatory (if not already present) for real-time BP monitoring during cement insertion 1
  • Set automated BP cuff to "stat" mode as backup during cementation 1
  • Continuous ECG telemetry for arrhythmia detection 2
  • End-tidal CO₂ monitoring (sudden drop indicates right heart failure/catastrophic CO reduction) 1

Anesthetic Technique

  • General anesthesia is preferred over neuraxial in patients with significant aortic stenosis or hemodynamic instability 1
  • Target systolic BP within 20% of pre-induction baseline 1
  • Avoid hypotension (SBP <85 mmHg) which worsens end-organ perfusion 1

Dobutamine Management Intra-Operatively

  • Continue dobutamine infusion throughout surgery without interruption 1
  • Have vasopressors prepared and immediately available (norepinephrine 0.2–1.0 µg/kg/min preferred over dopamine) 1
  • If additional inotropic support needed, dobutamine dose may be increased up to 20 µg/kg/min 1
  • In patients on chronic β-blockers, dobutamine doses may need to reach 20 µg/kg/min to restore inotropic effect 1

Bone Cement Implantation Syndrome Prevention

Three-Stage Protocol 1

Stage 1: Pre-Cementation Preparation

  • Confirm arterial line functioning and set BP cuff to "stat" mode 1
  • Surgeon must announce: "Preparing to insert cement" 1
  • Anesthesiologist confirms readiness and awareness 1
  • Prepare vasopressors at bedside (norepinephrine or phenylephrine drawn up) 1

Stage 2: Surgical Technique

  • Surgeon thoroughly washes and dries femoral canal 1
  • Apply cement in retrograde fashion using cement gun with suction catheter and intramedullary plug 1
  • Avoid vigorous pressurization of cement in this high-risk patient with cardiovascular compromise 1

Stage 3: Vigilant Monitoring

  • Watch for sudden drop in systolic BP (early warning of cardiovascular collapse) 1
  • Monitor end-tidal CO₂ (sudden drop indicates right heart failure/reduced cardiac output) 1
  • Immediately treat hypotension with vasopressors if SBP drops >20% from baseline 1

Post-Operative Management

Dobutamine Weaning Strategy

  • Do not abruptly discontinue dobutamine 1
  • Gradual tapering essential: decrease by 2 µg/kg/min increments 1
  • Simultaneous optimization of oral heart failure therapy (ACE inhibitor, β-blocker, diuretics) 1
  • Monitor for signs of decompensation during wean: rising lactate, falling urine output, worsening mental status 1

Hemodynamic Targets Post-Op

  • Systolic BP >90 mmHg 1
  • Cardiac index >2.0 L/min/m² 1
  • Urine output >0.5 mL/kg/h 1
  • Lactate <2 mmol/L 1

Pain Management

  • Multimodal analgesia to minimize opioid requirements (opioids can depress respiration and worsen heart failure) 1
  • Regional analgesia (femoral nerve block) if not contraindicated 1

Mobilization

  • Early physiotherapy (within 24 hours) to prevent complications 1
  • Gradual mobilization with hemodynamic monitoring 1

High-Risk Complications to Monitor

Cardiovascular

  • Arrhythmias (atrial fibrillation, ventricular tachycardia)—dobutamine increases risk in dose-dependent manner 2
  • Patients with pre-existing atrial fibrillation at highest risk for rapid ventricular response 2
  • Myocardial ischemia (dobutamine increases myocardial oxygen demand) 1
  • Acute decompensated heart failure 1

Cement-Related

  • Bone cement implantation syndrome (hypotension, hypoxia, arrhythmia, cardiac arrest) 1
  • Right heart failure from cement/fat embolization 1

General Surgical

  • Pressure ulcers (increased risk with prolonged immobility) 1
  • Pneumonia 1
  • Venous thromboembolism 1

Disposition Planning

  • ICU/step-down bed post-operatively for continued dobutamine infusion and hemodynamic monitoring
  • Cardiology consultation for heart failure optimization and dobutamine weaning plan
  • Orthogeriatric co-management throughout hospitalization 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dobutamine‑Induced Tachycardia: Mechanism, Risk Factors, Dose‑Response, and Monitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the protocol for administering dobutamine to a patient with considerations for age, weight, and medical history?
What is the role of dobutamine (inotropic agent) in managing acute decompensation in patients with dilated cardiomyopathy (DCM)?
What is the best course of action for a patient with severe heart failure exacerbation, hypotension, and tachycardia, requiring intravenous dobutamine (a beta-adrenergic agonist)?
What is the recommended dose of dobutamine (inotropic agent) for infusion in a patient requiring inotropic support?
What is the appropriate starting dose and administration protocol for a dobutamine drip?
What are the first‑line oral agents for uncomplicated cellulitis in patients without methicillin‑resistant Staphylococcus aureus risk, what regimens are recommended for diabetic patients with cellulitis, and when is combination therapy indicated?
Is it safe for a healthy adult without hypercholesterolemia, cardiovascular disease, diabetes, or other metabolic disorders to eat three boiled eggs daily?
What is the emergent management of suspected testicular torsion in an adolescent male with sudden severe unilateral scrotal pain, a high‑riding testis, absent cremasteric reflex, and possible nausea or vomiting?
What are the indications, dosing regimen, administration procedure, monitoring, and contraindications for intravenous ferric carboxymaltose in adults with iron‑deficiency anemia?
In a patient with atopic dermatitis whose eczema is well‑controlled and skin barrier intact, is it safe to use a facial vitamin C (L‑ascorbic acid) serum and what benefits does it offer?
Is the use of Fleet enema (sodium phosphate rectal solution) safe during pregnancy, particularly in the first trimester?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.